Drawing for CYTOCOM

USPTO serial 90318173

CYTOCOM

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SHINER, MARK W
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CYTOCOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J. O'Malley

John J. O'Malley Volpe Koenig30 South 17th StreetSuite 1800Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immunocompromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplementsACTIVE—
041Educational services, namely, conducting classes, seminars, conferences, and workshops in the medical, pharmaceutical, and healthcare fields and distributing printed course materials in conjunction therewith; providing online journals, namely, blogs in the medical, pharmaceutical and health fieldsACTIVE—
042Medical and pharmaceutical research services; pharmaceutical research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 13, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 13, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 13, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 10, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 12, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 12, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 12, 2021GNSLLETTER OF SUSPENSION E-MAILED—
May 12, 2021CNSLSUSPENSION LETTER WRITTEN—
May 12, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 12, 2021PBTQWITHDRAWN FROM PUB OTQR REQUEST—
May 7, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Apr 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 23, 2021DOCKASSIGNED TO EXAMINER—
Jan 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance